LEXINGTON, Mass.--(BUSINESS WIRE)--Feb. 28, 2006--NitroMed Inc. (NASDAQ: NTMD) today announced that it will present at the SG Cowen & Co. 26th Annual Health Care Conference, being held March 6 - 9 at The Boston Marriott Copley Place. Michael D. Loberg, Ph.D., NitroMed’s President and Chief Executive Officer, will present a corporate overview and progress report on the commercial launch of BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride) on Monday, March 6, at 4:00 pm (ET).
